SCHEMBL6943378

SCHEMBL6943378

N#Cc1ccc(/C=C/C=C/C=O)cc1

nearest known ligand 0.53

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HDAC2 Q92769 2/20 0.53
FBP1 P09467 4/20 0.50
ALDH1A1 P00352 5/20 0.45
MAPT P10636 3/20 0.45
KDM4E B2RXH2 2/20 0.45
LMNA P02545 3/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
P4HB P07237 1/20 0.44
TRPA1 O75762 1/20 0.43
ALOX5 P09917 1/20 0.43
MAPK1 P28482 1/20 0.43
HTT P42858 1/20 0.41
APP P05067 3/20 0.40
SNCA P37840 1/20 0.40
GAA P10253 1/20 0.39
NR1H3 Q13133 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6943381 1.00 HDAC2 (0.53) HDAC2FBP1ALDH1A1MAPTKDM4E
SCHEMBL628779 0.92 ALDH1A1 (0.54) HDAC2FBP1ALDH1A1MAPTKDM4E
SCHEMBL1819167 0.92 ALDH1A1 (0.54) HDAC2FBP1ALDH1A1MAPTKDM4E
SCHEMBL9971655 0.87 HDAC2 (0.58) HDAC2FBP1ALDH1A1MAPTKDM4E
SCHEMBL18921375 0.86 FBP1 (0.49) HDAC2FBP1ALDH1A1MAPTKDM4E
SCHEMBL18921374 0.86 FBP1 (0.49) HDAC2FBP1ALDH1A1MAPTKDM4E
SCHEMBL29966035 0.80 FBP1 (0.50) HDAC2FBP1ALDH1A1MAPTKDM4E
SCHEMBL11329021 0.79 MAOB (0.61) HDAC2FBP1ALDH1A1MAPTKDM4E
SCHEMBL11329024 0.79 MAOB (0.61) HDAC2FBP1ALDH1A1MAPTKDM4E
Benzonitrile SCHEMBL8349605 0.79 APP (0.59) FBP1ALDH1A1MAPTLMNAL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1083175-B1 Triazole derivatives having antifungal activity SANKYO CO (JP) 2003-07-02 EP disclosed
US-6392082-B1 CHEMICAL INTERMEDIATE SANKYO COMPANY, LIMITED (JP) 2002-05-21 US disclosed
US-6391903-B1 THERAPY FOR FUNGI INFECTIONS SANKYO COMPANY, LIMITED (JP) 2002-05-21 US disclosed
US-6337403-B1 CRYSTALLINE FORM OF A PHARMACEUTICAL COMPOSITION CONTAINING SAID DERIVATIVES WITH TREATING AND PREVENTING FUNGAL INFECTIONS USING BUTADIENE FLUORO BENZONITRILE GROUPS SANKYO COMPANY, LIMITED (JP) 2002-01-08 US disclosed
EP-1083175-A2 Triazole derivatives having antifungal activity Sankyo Company Limited (JP) 2001-03-14 EP disclosed